ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Porphyrias: Clinical Classifications, Physical Presentations, Diagnosis And Treatment

Updated on February 18, 2014

Clinical Presentations Of Porphyrias

Source

A General Overview

These are rare metabolic errors involving enzymes concered with the heme synthetic pathway. Most of these disorders are inherited, but porphyria cutanea tarda can be acquired. The synthesis of heme involves 8 steps and each step is enzymatically mediated. These are:

Glycine--------- Delta-aminolevulinic acid------------------ Porphobilinogen--------------- Polypyrrole------------- Uroporphyrinogen III------------------ Coproporphyrinogen III------------ Protoporphyrinogen III--------------------- Protoporphyrin III--------------- Heme.

In prophyrias, the skin and nervous system are predominantly involved. Excess porphyrins in the skin induce photosensitization and cause further damage. The pathogenesis of neural lesions is not fully understood. Porphyrias can be classified in different ways.

  1. Depending on the organ in which excess of metabolites are produced
  2. Clinical manifestations, and
  3. Specific enzyme defects

Clinical classification:

  1. Cutaneous manifestation without neurological features: Congenital erythropoietic porphyria, erythrohepatic porphyria (erythropoietic protoporphyria), porphyria cutanea tarda.
  2. Neurological features without skin lesions: Acute intermittent porphyria.
  3. Those that produce either cutaneous or neurological disease: Varigate porphyria (Porphyria varigata), hereditary coproporphyria.

Among the porphyrias, the most commonly encountered one is acute intermittent porphyria.

Signs Of Acute Intermittent Porphyria

Source

Acute Intermittent Porphyria

It occurs worldwide. It is inherited as autosomal dominant. Women suffer more than men. Basic defect is a gross reduction (below 50%) of uroporphyrinogen I synthase which is required for the conversion of porphobilinogen to polypyrole. Urine contains the porphyrin precursors porphobilinogen (PBG) and delta-aminolevulinic acid (ALA) even when the disease is asymptomatic. During acute attacks, these metabolites increase in amounts. In addition, urinary uro and coproporphyrins also may increase.

Clinical features: The condition may remain latent for long periods without recognition. Acute episodes are precipitated by several factors. Important among them are:

  1. Drugs- barbiturate, sulpha drugs, griseofulvin, phenytoin, female sex hormones and several others.
  2. Dietary factors- starvation or excess eating; and
  3. Infections.

The acute attack is characterized by neurological phenomena and acute abdominal pain. Excitement, behavioural disturbances, depression, suicidal tendency, delirium, convulsions and coma are frequent. Peripheral neuropathy and mononeuropathies may be prominent in some cases. Autonomic neuropathy results in gastrointestinal dysfunction, urinary retention, hypertensive crises, disordered sweating and tachycardia.

Abdominal pain may be so severe as to be mistaken for a surgical emergency. Severe constipation or diarrhea may occur. Gastrointestinal fluid losses lead to hyponatremia and dehydration.

Diagnosis: Acute intermittent porphyria should be considered in the differential diagnosis of all bizarre neurological and neuropsychiatric disorders, severe abdominal pain and autonomic disturbances. Diagnosis is established by urine examination. Freshly passed urine is colourless but on standing for a few hours at room temperature, it becomes portwine in colour and this should be looked for in all cases. Porphobilinogen (PBG) in urine can be demonstrated by Watson- Schwartz test i.e. the urine gives a pink colour with Ehrlich’s aldehyde reagent just as in the case of urobilinogen. On extracting the pigment with chloroform, PBG is not extractable, whereas urobilinogen is. The amount of PBG can be estimated quantitatively.

Apart from acute intermittent porphyria, PBG may occur in urine in hepatic diseases, drug toxicity, porphyria variegata and hereditary coproporphyria. Specific diagnostic test is the demonstration of diminution of uroporphyrin I synthetase in erythrocytes.

Treatment- Symptomatic Management during an attack: The offending drugs should be stopped. Phenothiazine (chlorpromazine) administered in a dose of 50 mg intramuscularly relieves abdominal pain and the hypertension. Maintenance of fluid and electrolyte balance helps to tide over the crisis. High carbohydrate intake and propranolol give symptomatic relief. Aspirin, morphine, guanethidine, reserpine and penicillin can be safely used for suitable indications.

Prophylaxis should be in the form of avoidance of precipitating factors. Relatives should be screen for the enzyme deficiency and susceptible persons should be warned to avoid the offending drugs.

© 2014 Funom Theophilus Makama

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)